
The European venture capital firm Sofinnova, which specializes in life sciences and healthcare, has raised its tenth life science fund for startups in Europe, writes the European business media Sifted.
The life science fund has backed some unicorn companies – which is a startup valued at USD 1bn – like Ascendis Pharma, Shockwave and Actelion.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app